MAPK3 and triple-negative breast carcinoma: What’s more, although p-ERK1/2 is always highly expressed, we did found triple-negative breast cancer showed much greater expression than non-triple negative breast cancer (38.6% vs 0.9%; p<0.001; Table 1).